News & Updates

Show Multimedia Only
Very low HBsAg levels predict HBsAg loss, disease remission after therapy cessation

Very low HBsAg levels predict HBsAg loss, disease remission after therapy cessation

04 Jun 2022

Following discontinuation of nucleot(s)ide analogue therapy, only about one-third of patients with HBeAg-negative chronic hepatitis B (CHB) achieve disease remission, with rare HBsAg loss, as reported in a study. The likelihood of HBsAg loss and disease remission is high in the presence of very low HBsAg levels at baseline.

Very low HBsAg levels predict HBsAg loss, disease remission after therapy cessation

04 Jun 2022
Losing weight may help control cardiovascular risk in T2D

Losing weight may help control cardiovascular risk in T2D

04 Jun 2022